Related Experiment Video
Updated: Aug 16, 2025
12:17
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
11.4K
Evaluating the Effectiveness of Stenting for Aortic Coarctation
Constantinos Contrafouris1, Constantine N Antonopoulos2, Spyridon Rammos3
11st Cardiac Surgery Department, "Onassis" Cardiac Surgery Center, Athens, Greece.
Aorta (Stamford, Conn.)
|December 20, 2022
Summary
Endovascular stenting effectively treats coarctation of the aorta (CoA), improving aortic diameter and blood pressure gradients. Both bare and covered stents showed similar positive hemodynamic effects in patients with CoA.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Engineering
Background:
- Coarctation of the aorta (CoA) is a congenital narrowing of the thoracic aorta.
- This condition requires effective treatment to prevent cardiovascular complications.
Purpose of the Study:
- To evaluate the hemodynamic effects of endovascular treatment for coarctation of the aorta (CoA).
- To compare the efficacy of bare (bCP) versus covered (cCP) Cheatham-Platinum stents in CoA treatment.
Main Methods:
- Retrospective evaluation of 47 patients with CoA treated with stent implantation (2003-2019).
- Invasive aortic pressure measurements were recorded before and after endovascular intervention.
- Comparison of hemodynamic outcomes between bCP and cCP stent groups.
Main Results:
- Endovascular stenting significantly increased aortic diameter at the CoA lesion (9.7 to 19.2 mm).
- Mean blood pressure in the descending aorta increased, while in the ascending aorta it decreased post-intervention.
- Both bCP and cCP stents effectively reduced the mean aortic blood pressure gradient, with no significant difference between stent types.
Conclusions:
- Invasive aortic catheterization confirms the efficiency of endovascular stenting for treating coarctation of the aorta.
- Both bare and covered Cheatham-Platinum stents are effective treatment options for CoA, yielding similar hemodynamic improvements.
Related Concept Videos
01:25Aortic Regurgitation III: Medical Management
32
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
32
01:26Aneurysm III: Interprofessional Care
17
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
17
01:26Mitral Stenosis III: Medical Management
16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16